Form 8-K - Current report:
SEC Accession No. 0001144204-08-029399
Filing Date
2008-05-15
Accepted
2008-05-15 13:53:50
Documents
5
Period of Report
2008-05-12
Items
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT v114248_8k.htm 8-K 36203
2 FORM OF SUBSCRIPTION AGREEMENT v114248_ex10-1.htm EX-10.1 97900
3 FORM OF WARRANT FOR SUBSCRIBERS v114248_ex10-2.htm EX-10.2 86288
4 PRESS RELEASE DATED MAY 15, 2008 v114248_ex99-1.htm EX-99.1 14466
5 GRAPHIC logo.jpg GRAPHIC 16414
  Complete submission text file 0001144204-08-029399.txt   259286
Mailing Address 4225 EXECUTIVE SQUARE SUITE 460 LA JOLLA CA 92037
Business Address 4225 EXECUTIVE SQUARE SUITE 460 LA JOLLA CA 92037 (858) 457-5300
TRANSDEL PHARMACEUTICALS INC (Filer) CIK: 0001360214 (see all company filings)

EIN.: 450567010 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-52998 | Film No.: 08836004
SIC: 2834 Pharmaceutical Preparations